Characteristics of Helicobacter pylori Eradication Therapy in Patients 80 Years or Older Living in a Metropolitan Area: A Multicenter Retrospective Study

医学 幽门螺杆菌 内科学 置信区间 大都市区 消化性 消化性溃疡 胃肠病学 病理
作者
Eri Iwata,Mitsushige Sugimoto,Daisuke Asaoka,Mariko Hojo,Masayoshi Ito,Naoko Kitazawa,Naoto Kurihara,Tatsuhiro Masaoka,Shigeaki Mizuno,Hideki Mori,Akihito Nagahara,Ryota Niikura,Toshifumi� Ohkusa,Masaya Sano,Yuji Shimada,Hidekazu Suzuki,Yoshiaki Takeuchi,Akifumi Tanaka,K. Tokunaga,Kumiko Ueda
出处
期刊:Helicobacter [Wiley]
卷期号:29 (4): e13125-e13125 被引量:3
标识
DOI:10.1111/hel.13125
摘要

ABSTRACT Background The situation of Helicobacter pylori eradication therapy has been changing over time, owing to increases in antimicrobial‐resistant strains, lifestyle improvements, and changes in indications for eradication. In Japan, eradication therapy is now available to all H. pylori ‐positive patients under the medical insurance system, and the potassium‐competitive acid blocker vonoprazan has been used for eradication from 2015. Recently, with the aging of society, opportunities to provide eradication to elderly patients are increasing, but the current status and effectiveness of eradication in elderly patients remains unclear. Therefore, we aimed to investigate the trends of H. pylori eradication in a metropolitan area to determine the factors associated with successful H. pylori eradication in elderly patients older than 80 years. Methods Trends in the eradication rates of patients who received first‐ or second‐line eradication at 20 hospitals in the Tokyo metropolitan area from 2013 to 2023 were investigated. Results The eradication rates in the per‐protocol analysis were 82.3% (95% confidence interval [CI]: 81.2%–83.2%) for the first‐line treatment ( n = 6481), and 87.9% (86.9%–88.9%) for the second‐line treatment ( n = 4899). Multivariate analysis showed that independent factors for successful eradication in the first‐line treatment were an age of older than 80 years (OR: 0.606; 95% CI: 0.448–0.822), peptic ulcers (vs. atrophic gastritis: 3.817; 3.286–4.433), and vonoprazan (vs. proton pump inhibiters (PPIs), 3.817; 3.286–4.433), and an age of older than 80 years (0.503; 0.362–0.699) and vonoprazan (1.386; 1.153–1.667) in the second‐line treatment. Conclusion After 2015, the eradication rate of both first‐ and second‐line therapies were maintained at a higher level than before 2015, owing to the use of vonoprazan. As the H. pylori eradication rate in patients older than 80 years was low, an effective strategy for these patients needs to be developed in the future.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
陈月亮发布了新的文献求助10
刚刚
1秒前
风吹麦浪的应助被水天需采纳,获得10
2秒前
YoungY完成签到,获得积分10
2秒前
2秒前
顾矜的应助被tjzbw采纳,获得10
2秒前
3秒前
4秒前
4秒前
lilili的应助被xujiahao采纳,获得10
4秒前
晨曦发布了新的文献求助10
5秒前
XZM发布了新的文献求助10
5秒前
中中中发布了新的文献求助10
5秒前
逆水行舟发布了新的文献求助10
5秒前
Wuwj完成签到 ,获得积分10
5秒前
青椒豆丝完成签到 ,获得积分10
6秒前
8秒前
Lynn完成签到,获得积分10
9秒前
Bigmouse完成签到 ,获得积分10
9秒前
zhhhh完成签到,获得积分20
9秒前
万能图书馆的应助被慕慕君卿采纳,获得10
10秒前
丘比特的应助被初初初啊采纳,获得10
11秒前
情怀的应助被Meng采纳,获得10
11秒前
ping发布了新的文献求助10
13秒前
斯文败类的应助被大碗宽面采纳,获得10
13秒前
Maestro_S的应助被酱鱼采纳,获得10
13秒前
JamesPei的应助被陈月亮采纳,获得10
14秒前
水弘的应助被renn采纳,获得10
14秒前
小y完成签到,获得积分10
15秒前
15秒前
秋风的应助被lin采纳,获得20
17秒前
Charlie完成签到,获得积分10
18秒前
18秒前
18秒前
19秒前
19秒前
XJ发布了新的文献求助10
20秒前
21秒前
烟花的应助被耳东采纳,获得10
21秒前
慕慕君卿发布了新的文献求助10
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184008
求助须知:如何正确求助?哪些是违规求助? 9573151
关于积分的说明 21829656
捐赠科研通 7781040
什么是DOI,文献DOI怎么找? 3434187
关于科研通互助平台的介绍 2558337
邀请新用户注册赠送积分活动 2480658